| scholarly article | Q13442814 |
| P2093 | author name string | Steven M Scharf | |
| Joseph Finkelstein | |||
| Eunme Cha | |||
| P2860 | cites work | Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study | Q37411599 |
| Monitoring respiratory disease severity in cystic fibrosis | Q37459079 | ||
| Assessment of a national health interview survey-based method of measuring community socioeconomic status | Q38425606 | ||
| Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study | Q39778004 | ||
| Reduced lung function predicts increased fatality in future cardiac events. A population-based study. | Q40268331 | ||
| A comparison of respiratory conditions between multiple race adults and their single race counterparts: an analysis based on American Indian/Alaska Native and white adults. | Q40407406 | ||
| Abnormal myocardial repolarisation in response to hypoxaemia and fenoterol | Q41232825 | ||
| Hospitalizations and mortality in the Lung Health Study | Q44086880 | ||
| Pulmonary function in multiple sclerosis without any respiratory complaints. | Q44366314 | ||
| Cardiovascular morbidity and mortality in COPD. | Q44933278 | ||
| Cardiovascular events associated with ipratropium bromide in COPD. | Q46052755 | ||
| COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program | Q46262235 | ||
| Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease | Q46365320 | ||
| Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males | Q46414701 | ||
| Body composition and resting energy expenditure in clinically stable, non-weight-losing patients with severe emphysema | Q47439911 | ||
| Patterns of comorbidities in newly diagnosed COPD and asthma in primary care | Q47706912 | ||
| Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. | Q47707059 | ||
| Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease | Q29547385 | ||
| Agreement between questionnaire data and medical records. The evidence for accuracy of recall | Q31001105 | ||
| The risk of myocardial infarction associated with inhaled beta-adrenoceptor agonists | Q33860221 | ||
| COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity | Q34637487 | ||
| Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis | Q34835363 | ||
| Definition, epidemiology, course, and prognosis of COPD | Q35124448 | ||
| The burden of illness and economic evaluation for COPD. | Q35149034 | ||
| Inhaled short acting beta agonist use in COPD and the risk of acute myocardial infarction | Q35535399 | ||
| Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis | Q35536791 | ||
| Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease | Q36067003 | ||
| The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature | Q36157802 | ||
| Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality | Q36236967 | ||
| Cardiovascular disease in chronic obstructive pulmonary disease | Q36236990 | ||
| Clinical approach to patients with chronic obstructive pulmonary disease and cardiovascular disease | Q36237017 | ||
| Neurohumoral activation as a link to systemic manifestations of chronic lung disease | Q36320236 | ||
| Cardiovascular morbidity and the use of inhaled bronchodilators | Q36859429 | ||
| Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data | Q36884246 | ||
| Impact of statins and ACE inhibitors on mortality after COPD exacerbations | Q37231396 | ||
| Comparisons of self-reported and chart-identified chronic diseases in inner-city seniors. | Q37401187 | ||
| Symptoms of chronic bronchitis and the risk of coronary disease. | Q50536631 | ||
| Validity of self-reported hypertension in the National Health and Nutrition Examination Survey III, 1988-1991. | Q50625463 | ||
| Comparison of NIS and NHIS/NIPRCS vaccination coverage estimates. National Immunization Survey. National Health Interview Survey/National Immunization Provider Record Check Study. | Q50674099 | ||
| Heart rate variability reflects severity of COPD in PiZ alpha1-antitrypsin deficiency. | Q50903203 | ||
| Resting energy expenditure in patients with chronic obstructive pulmonary disease. | Q52435644 | ||
| Statistical methods in cancer research. Volume I - The analysis of case-control studies. | Q52768696 | ||
| Respiratory Function as a Marker of Bone Health and Fracture Risk in an Older Population | Q57306138 | ||
| Coronary Artery Calcification in Older Adults to Age 99 | Q57392472 | ||
| Chronic Obstructive Pulmonary Disease, Asthma, and Risk of Type 2 Diabetes in Women | Q57749967 | ||
| Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Saskatchewan Canada | Q57756390 | ||
| Arterial Stiffness and Osteoporosis in Chronic Obstructive Pulmonary Disease | Q58057647 | ||
| Systemic effects of chronic obstructive pulmonary disease | Q58840542 | ||
| Obesity Is Associated With Altered Lung Function Independently of Physical Activity and Fitness | Q59562215 | ||
| Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study | Q61875240 | ||
| Methodological issues in estimating smoking-attributable mortality in the United States | Q64130269 | ||
| Bronchodilators and acute cardiac death | Q71906902 | ||
| The validity of self-reported hypertension and correlates of hypertension awareness among blacks and whites within the stroke belt | Q72029648 | ||
| Respiratory decline in smokers and ex-smokers--an independent risk factor for cardiovascular disease and death | Q73008649 | ||
| National Health Interview Survey: research for the 1995-2004 redesign | Q73015396 | ||
| Design and estimation for the National Health Interview Survey, 1995-2004 | Q77168152 | ||
| Lung function and incident coronary heart disease: the Atherosclerosis Risk in Communities Study | Q79339446 | ||
| Racial/ethnic differences in influenza vaccination coverage in high-risk adults | Q79339477 | ||
| Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes | Q79817388 | ||
| Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability | Q81338893 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circulatory system | Q11068 |
| risk factor | Q1475848 | ||
| chronic obstructive pulmonary disease | Q199804 | ||
| P304 | page(s) | 337-349 | |
| P577 | publication date | 2009-09-24 | |
| P1433 | published in | International Journal of Chronic Obstructive Pulmonary Disease | Q6051335 |
| P1476 | title | Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity | |
| P478 | volume | 4 |
| Q98770627 | 'Utilization of telemetry monitoring for non-cardiac conditions in non-critical patients: what are the trends and perceptions amongst medical residents?' |
| Q38939665 | A Use Case to Support Precision Medicine for Frequently Hospitalized Older Adults with Polypharmacy |
| Q40067256 | A comprehensive analysis of association of medical history with airflow limitation: a cross-sectional study |
| Q51693992 | A perspective on point-of-care tests to detect eosinophilic bronchitis. |
| Q28072014 | A review of national guidelines for management of COPD in Europe |
| Q37644823 | Acute exacerbation of chronic obstructive pulmonary disease: cardiovascular links |
| Q36110325 | Adherence to Oral Medications for Hypertension and Diabetes in Veterans with Comorbid Airflow Limitation |
| Q89259179 | Age density patterns in patients medical conditions: A clustering approach |
| Q38688695 | Airway obstruction and the risk of myocardial infarction and death from coronary heart disease: a national health examination survey with a 33-year follow-up period |
| Q26746530 | COPD and stroke: are systemic inflammation and oxidative stress the missing links? |
| Q57785897 | COPD patients with and without metabolic syndrome: clinical and functional differences |
| Q89496069 | Cardiovascular Comorbidity in Patients with Chronic Obstructive Pulmonary Disease: Echocardiography Changes and Their Relation to the Level of Airflow Limitation |
| Q92922217 | Carotid Artery Disease and Lower Extremities Artery Disease in Patients with Chronic Obstructive Pulmonary Disease |
| Q60044287 | Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort |
| Q38944856 | Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care |
| Q39268464 | Chronic Obstructive Pulmonary Disease and the Risk of Stroke |
| Q41297968 | Chronic Obstructive Pulmonary Disease and the Risk of Stroke. The Rotterdam Study |
| Q41589762 | Chronic Respiratory Diseases in the Regions of Northern Russia: Epidemiological Distinctions in the Results of a National Population Study |
| Q38111151 | Chronic obstructive pulmonary disease and cardiovascular disease |
| Q37516810 | Chronic obstructive pulmonary disease and the risk of stroke: a systematic review protocol. |
| Q36308003 | Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study). |
| Q46204206 | Chronic obstructive pulmonary disease as a risk factor for ventricular arrhythmias independent of left ventricular function |
| Q36443665 | Chronic obstructive pulmonary disease: an update of treatment related to frequently associated comorbidities |
| Q47721405 | Commencement of cardioselective beta-blockers during hospitalisation for acute exacerbations of chronic obstructive pulmonary disease |
| Q26823339 | Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease |
| Q38155898 | Coronary artery disease concomitant with chronic obstructive pulmonary disease |
| Q37066051 | Coronary artery disease is under-diagnosed and under-treated in advanced lung disease. |
| Q38068458 | Delivering cost-effective care for COPD in the USA: recent progress and current challenges. |
| Q34547146 | Determinants of elevated healthcare utilization in patients with COPD |
| Q46942402 | E-cigarettes in patients with COPD: current perspectives |
| Q36412770 | Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk |
| Q34134841 | Epidemiology and clinical impact of major comorbidities in patients with COPD. |
| Q89249260 | Evaluation of Pregnancy-Associated Plasma Protein-A Levels in Patients with Chronic Obstructive Pulmonary Disease and Associations with Disease Severity |
| Q37510906 | Evidence for harm reduction in COPD smokers who switch to electronic cigarettes |
| Q38085133 | Exercise and COPD: therapeutic responses, disease-related outcomes, and activity-promotion strategies |
| Q35184792 | Factors associated with prolonged hospitalization, readmission, and death in elderly heart failure patients in western Romania |
| Q40389605 | Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey |
| Q51272802 | Gender-related differences in hospitalized heart failure patients. |
| Q37053317 | Helping COPD patients change health behavior in order to improve their quality of life |
| Q34090416 | Human endothelial progenitor cells isolated from COPD patients are dysfunctional. |
| Q52361012 | Identifying temporal patterns in patient disease trajectories using dynamic time warping: A population-based study. |
| Q35140970 | Impact of COPD on the mortality and treatment of patients hospitalized with acute decompensated heart failure: the Worcester Heart Failure Study |
| Q37500727 | Impact of Chronic Obstructive Pulmonary Disease on Long-Term Outcome in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention |
| Q35767140 | Impact of chronic inflammatory airway disease on stroke severity and long-term survival after ischemic stroke--a retrospective analysis |
| Q83831164 | Impact of chronic obstructive pulmonary disease severity on symptoms and prognosis in patients with systolic heart failure |
| Q104064760 | Impact of tobacco-related chronic obstructive pulmonary disease on developmental trajectories of comorbidities in the Taiwan population |
| Q44210553 | Increased prevalence of obstructive lung disease in patients with obstructive sleep apnea |
| Q35897669 | Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer |
| Q30654188 | Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis |
| Q90177790 | Intake of high fructose corn syrup sweetened soft drinks, fruit drinks and apple juice is associated with prevalent coronary heart disease, in U.S. adults, ages 45-59 y |
| Q38598984 | Ischemic ECG abnormalities are associated with an increased risk for death among subjects with COPD, also among those without known heart disease |
| Q35861330 | Ischemic heart disease among subjects with and without chronic obstructive pulmonary disease--ECG-findings in a population-based cohort study. |
| Q29248734 | Lung Function, Percent Emphysema, and QT Duration: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study |
| Q35600825 | Lung deflation and oxygen pulse in COPD: results from the NETT randomized trial |
| Q38821380 | Machine learning approaches to personalize early prediction of asthma exacerbations |
| Q27005858 | Managing comorbidities in COPD |
| Q42853726 | Metabolic syndrome is associated with increased risk of acute exacerbation of COPD: a preliminary study |
| Q37780450 | Nebulized formoterol: a review of clinical efficacy and safety in COPD. |
| Q37947846 | Neurological and endocrinological disorders: orphans in chronic obstructive pulmonary disease |
| Q40655628 | Potential utility of precision medicine for older adults with polypharmacy: a case series study |
| Q34430477 | Prevalence and risk factors of aortic aneurysm in patients with chronic obstructive pulmonary disease |
| Q33709381 | Prevalence of airflow limitation in outpatients with cardiovascular diseases in Japan |
| Q57312139 | Prevalence of undiagnosed COPD in male patients with coronary artery disease: a cross-sectional study in Jordan |
| Q41728444 | Prevalence, Risk Factors and Diagnostic Accuracy of COPD Among Smokers in Primary Care |
| Q93027457 | Revealing Methodological Challenges in Chronic Obstructive Pulmonary Disease Studies Assessing Comorbidities: A Narrative Review |
| Q38553747 | Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis |
| Q28602715 | Self-reported symptoms of chronic cough and breathlessness in working-age men in the city of Izhevsk, Russia: associations with cardiovascular disease risk factors and comorbidities |
| Q34253499 | Serial pulmonary function tests to diagnose COPD in chronic heart failure |
| Q55264999 | Significance of prolonged QTc in acute exacerbations of COPD requiring hospitalization. |
| Q58131525 | Spirometry in Hospitalized Patients with Acute Exacerbation of COPD Accurately Predicts Post Discharge Airflow Obstruction |
| Q55269439 | Surfactant Protein D in Respiratory and Non-Respiratory Diseases. |
| Q47650579 | Surrogate Markers of Cardiovascular Risk and Chronic Obstructive Pulmonary Disease: A Large Case-Controlled Study |
| Q30002373 | Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients |
| Q90733135 | The Dual Role of Surfactant Protein-D in Vascular Inflammation and Development of Cardiovascular Disease |
| Q37571664 | The Role of Mitochondria and Oxidative/Antioxidative Imbalance in Pathobiology of Chronic Obstructive Pulmonary Disease |
| Q36555278 | The Swedish CArdioPulmonary BioImage Study: objectives and design |
| Q48525384 | The association of metabolic syndrome with adipose tissue hormones and insulin resistance in patients with COPD without co-morbidities |
| Q36204236 | The prognostic value of measurement of high-sensitive cardiac troponin T for mortality in a cohort of stable chronic obstructive pulmonary disease patients |
| Q46123615 | The role of the β2 adrenergic receptor on endothelial progenitor cells dysfunction of proliferation and migration in chronic obstructive pulmonary disease patients |
| Q33650636 | Tobacco Smoke Exposure Reduces Paraoxonase Activity in a Murine Model |
| Q90730661 | Tracing diagnosis trajectories over millions of patients reveal an unexpected risk in schizophrenia |
| Q35871744 | Underdiagnosis and prognosis of chronic obstructive pulmonary disease after percutaneous coronary intervention: a prospective study |
| Q26800282 | Underrecognized comorbidities of chronic obstructive pulmonary disease |
| Q40383327 | Undiagnosed airflow limitation is common in patients with coronary artery disease and associated with cardiac stress. |
| Q50795103 | [Alveolar epithelial cell injury as an etiopathogenic factor in pulmonary fibrosis]. |
| Q37978685 | β-blockade: benefits beyond blood pressure reduction? |
Search more.